世界の黒色腫診断＆治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Melanoma Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4487 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、黒色腫診断＆治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他）、用途別市場規模（病院、診断センター、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・黒色腫診断＆治療薬の市場動向 ・企業の競争状況、市場シェア ・黒色腫診断＆治療薬の種類別市場規模と予測2016-2027（結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他） ・黒色腫診断＆治療薬の用途別市場規模と予測2016-2027（病院、診断センター、医療機関、その他） ・黒色腫診断＆治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・黒色腫診断＆治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・黒色腫診断＆治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黒色腫診断＆治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・黒色腫診断＆治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Agilent Technologies、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、GlaxoSmithKline、Merck、Novartis、Pfizer、Qiagen、Roche、Sanofi） ・結論

Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.

Market Analysis and Insights: Global Melanoma Diagnostics and Therapeutics Market
The global Melanoma Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Diagnostics and Therapeutics market.

Global Melanoma Diagnostics and Therapeutics Scope and Market Size
Melanoma Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nodular Melanoma
Superficial Spreading Melanoma
Amelanotic Melanoma
Others

Segment by Application
Hospital
Diagnostic Center
Medical Institution
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Agilent Technologies
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nodular Melanoma
1.2.3 Superficial Spreading Melanoma
1.2.4 Amelanotic Melanoma
1.2.5 Others
1.3 Market by Application
1.3.1 Global Melanoma Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Medical Institution
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Melanoma Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Melanoma Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Melanoma Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Diagnostics and Therapeutics Industry Dynamic
2.3.1 Melanoma Diagnostics and Therapeutics Market Trends
2.3.2 Melanoma Diagnostics and Therapeutics Market Drivers
2.3.3 Melanoma Diagnostics and Therapeutics Market Challenges
2.3.4 Melanoma Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Melanoma Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Melanoma Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Diagnostics and Therapeutics Revenue
3.4 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Diagnostics and Therapeutics Revenue in 2020
3.5 Melanoma Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Melanoma Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Melanoma Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Melanoma Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Melanoma Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Melanoma Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Melanoma Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Melanoma Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Melanoma Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Melanoma Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Melanoma Diagnostics and Therapeutics Introduction
11.1.4 Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Introduction
11.2.4 Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Melanoma Diagnostics and Therapeutics Introduction
11.7.4 Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Melanoma Diagnostics and Therapeutics Introduction
11.8.4 Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Melanoma Diagnostics and Therapeutics Introduction
11.9.4 Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Melanoma Diagnostics and Therapeutics Introduction
11.10.4 Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Melanoma Diagnostics and Therapeutics Introduction
11.11.4 Roche Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Melanoma Diagnostics and Therapeutics Introduction
11.12.4 Sanofi Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.12.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nodular Melanoma
Table 3. Key Players of Superficial Spreading Melanoma
Table 4. Key Players of Amelanotic Melanoma
Table 5. Key Players of Others
Table 6. Global Melanoma Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Melanoma Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Melanoma Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Table 12. Melanoma Diagnostics and Therapeutics Market Trends
Table 13. Melanoma Diagnostics and Therapeutics Market Drivers
Table 14. Melanoma Diagnostics and Therapeutics Market Challenges
Table 15. Melanoma Diagnostics and Therapeutics Market Restraints
Table 16. Global Melanoma Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Melanoma Diagnostics and Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Melanoma Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Diagnostics and Therapeutics as of 2020)
Table 19. Ranking of Global Top Melanoma Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Melanoma Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Melanoma Diagnostics and Therapeutics Product Solution and Service
Table 23. Date of Enter into Melanoma Diagnostics and Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Melanoma Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Melanoma Diagnostics and Therapeutics Product
Table 66. Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Agilent Technologies Company Details
Table 69. Agilent Technologies Business Overview
Table 70. Agilent Technologies Melanoma Diagnostics and Therapeutics Product
Table 71. Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Agilent Technologies Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Melanoma Diagnostics and Therapeutics Product
Table 76. AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Product
Table 81. Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Eli Lilly Company Details
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Melanoma Diagnostics and Therapeutics Product
Table 86. Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Product
Table 91. GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Melanoma Diagnostics and Therapeutics Product
Table 96. Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Melanoma Diagnostics and Therapeutics Product
Table 105. Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Qiagen Company Details
Table 108. Qiagen Business Overview
Table 109. Qiagen Melanoma Diagnostics and Therapeutics Product
Table 110. Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Qiagen Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Melanoma Diagnostics and Therapeutics Product
Table 115. Roche Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Sanofi Company Details
Table 118. Sanofi Business Overview
Table 119. Sanofi Melanoma Diagnostics and Therapeutics Product
Table 120. Sanofi Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Sanofi Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Nodular Melanoma Features
Figure 3. Superficial Spreading Melanoma Features
Figure 4. Amelanotic Melanoma Features
Figure 5. Others Features
Figure 6. Global Melanoma Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Medical Institution Case Studies
Figure 10. Others Case Studies
Figure 11. Melanoma Diagnostics and Therapeutics Report Years Considered
Figure 12. Global Melanoma Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Melanoma Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Melanoma Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Melanoma Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Melanoma Diagnostics and Therapeutics Market Share by Players in 2020
Figure 17. Global Top Melanoma Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Diagnostics and Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Melanoma Diagnostics and Therapeutics Revenue in 2020
Figure 19. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Melanoma Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Melanoma Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Melanoma Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Melanoma Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Melanoma Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Melanoma Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Melanoma Diagnostics and Therapeutics Market Share by Region (2016-2027)
Figure 41. China Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Melanoma Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Melanoma Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Melanoma Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Melanoma Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Melanoma Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 61. Agilent Technologies Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 69. Qiagen Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 70. Roche Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Melanoma Diagnostics and Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---